Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial By: MarketWatch August 20, 2014 at 08:03 AM EDT Shares surge 40% in premarket trade on positive news from Phase 3 study. Read More >> Related Stocks: Amicus Therapeutics